Axitrix T 250mg/31.25mg Injection
By Axitrix T
Rx
1 Powder for Injection in a Vial

Composition
Ceftriaxone(250mg) + Tazobactum(31.25mg)

Manufacturer - Axis Life Science Pvt Ltd
371, green city, near krishna shalby hospital, ghuma, ahmedabad, gujarat 380058

Expires on or after
September, 2025

liver
When using Axitrix T 250mg/31.25mg Injection, it is important to be cautious if you have severe liver disease. In such cases, dose adjustment may be necessary, and it is advised to consult your doctor for appropriate guidance. However, for individuals with mild to moderate liver disease, dose adjustment of Axitrix T 250mg/31.25mg Injection is not typically recommended. It's crucial to prioritize your liver health and follow your healthcare provider's instructions carefully when using this medication.

kidney
Limited information is present on the use of Axitrix T 250mg/31.25mg Injection in patients with kidney disease. It is important to consult your doctor regarding its use in such cases.

alcohol
It is safe to consume alcohol with Axitrix T 250mg/31.25mg Injection as it does not cause harmful side effects.

driving
Axitrix T 250mg/31.25mg Injection may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Axitrix T 250mg/31.25mg Injection is generally safe during pregnancy based on animal studies, which show minimal risks to the baby. Human studies are limited, so consult your doctor if pregnant.

breastfeeding
During breastfeeding, caution should be taken when using Axitrix T 250mg/31.25mg Injection. It is advisable to hold off breastfeeding until the mother's treatment is finished and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹75
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024